IBM Stock Is Having the Worst Day in Its History

IBM shares fell as much as 25% (down ~26% YTD) after management issued a warning that Q2 earnings will be below expectations, citing clients reprioritizing capex from IBM products toward servers and storage—IBM said it underestimated the magnitude of this shift. Preliminary Q2 revenue was $17.2B (+1% YoY) with infrastructure revenue down 7%, while software rose 5%; management also said large deals failed to close on expected timelines. Analysts are responding with downgrades (HSBC from Hold to Reduce; price target cut from $231 to $191) ahead of full results on July 22.

Analysis

This is less about one company’s miss and more about a live budget rotation inside data-center capex: storage and memory are the first beneficiaries when customers front-load purchases ahead of expected pricing pressure, while legacy infrastructure vendors get squeezed on deal timing and mix. The immediate loser is IBM, but the more important market signal is that enterprise AI spend is still being funded by reallocation, not by wholesale IT budget expansion.

That makes MU and SNDK the cleaner second-order longs than any broad software basket. If the memory cycle stays tight, pricing leverage should show up before unit growth, which means the next 1-2 quarters can still surprise to the upside even if hyperscaler capex moderates later; the risk is that the stock market has already discounted the tightness and any inventory normalization will hit multiples fast.

For IBM, the key question is not the headline drop but whether this is a one-quarter execution slip or a sign that its mainframe/enterprise refresh cycle is losing priority versus AI infrastructure. A rebound hinges on July 22 commentary around bookings and backlogs; if those do not stabilize, the market will likely re-rate IBM as a low-growth cash generator rather than a software comp, which is a 6-18 month multiple problem, not just a one-day event. The brief sympathy weakness in CRM/MSFT looks more like mechanical read-through than fundamental damage unless CIOs start broadly delaying contract closures.

Contrarian view: the selloff in IBM may overshoot if investors ignore that the core software layer is still growing and the market is punishing an execution miss as if it were structural decay. But the burden of proof just shifted to management, and until they show bookings recovery, the stock deserves a lower multiple because credibility risk now sits on top of growth risk.

Key Decisions for Investors

• Long MU / short IBM as a 1-3 month relative-value pair: MU benefits from capex reallocation and memory tightness while IBM faces deal-timing and execution risk; exit if IBM restores bookings commentary or MU guides inventory digestion.
• Add SNDK on post-event weakness or via call spreads for a 1-2 quarter window: the trade is on pricing power and data-center mix, but reduce if channel checks show OEM/ hyperscaler order normalization.
• Do not short IBM aggressively after a 25% gap; wait for the July 22 print and only press on any rally into earnings if bookings, backlog, or free-cash-flow guidance remain under pressure.
• Avoid chasing CRM/MSFT sympathy weakness unless enterprise-spend checks deteriorate more broadly; at present the read-through is a timing issue, not a demand collapse.